CA2071425A1 - Composition prophylactique/therapeutique pour la coagulation intravasculaire disseminee, ou les infections chroniques des voies respiratoires - Google Patents
Composition prophylactique/therapeutique pour la coagulation intravasculaire disseminee, ou les infections chroniques des voies respiratoiresInfo
- Publication number
- CA2071425A1 CA2071425A1 CA2071425A CA2071425A CA2071425A1 CA 2071425 A1 CA2071425 A1 CA 2071425A1 CA 2071425 A CA2071425 A CA 2071425A CA 2071425 A CA2071425 A CA 2071425A CA 2071425 A1 CA2071425 A1 CA 2071425A1
- Authority
- CA
- Canada
- Prior art keywords
- prophylactic
- respiratory tract
- infectious disease
- therapeutic composition
- intravascular coagulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000001684 chronic effect Effects 0.000 title 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- 150000002148 esters Chemical class 0.000 abstract 2
- 239000008187 granular material Substances 0.000 abstract 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 abstract 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical class [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 abstract 1
- 239000008298 dragée Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000003094 microcapsule Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
- C07K4/04—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3-245283 | 1991-06-18 | ||
| JP3245283A JP2663763B2 (ja) | 1990-06-29 | 1991-06-18 | Ｗｓ７６２２ａジ硫酸エステル、その製造法およびその用途 |
| JP36113591 | 1991-12-19 | ||
| JP3-361135 | 1991-12-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2071425A1 true CA2071425A1 (fr) | 1992-12-19 |
| CA2071425C CA2071425C (fr) | 1997-02-04 |
Family
ID=26537148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002071425A Expired - Fee Related CA2071425C (fr) | 1991-06-18 | 1992-06-17 | Composition prophylactique/therapeutique pour la coagulation intravasculaire disseminee, ou les infections chroniques des voies respiratoires |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5279826A (fr) |
| EP (1) | EP0519354B1 (fr) |
| AT (1) | ATE161016T1 (fr) |
| CA (1) | CA2071425C (fr) |
| DE (1) | DE69223455T2 (fr) |
| DK (1) | DK0519354T3 (fr) |
| ES (1) | ES2111013T3 (fr) |
| GR (1) | GR3025656T3 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610748B1 (en) * | 1998-02-24 | 2003-08-26 | Fujisawa Pharmaceutical Co., Ltd. | Preventives/remedies for skin aging |
| WO2000057913A1 (fr) * | 1999-03-25 | 2000-10-05 | Welfide Corporation | Prophylaxies/remedes pour la pneumonie interstitielle et la fibrose pulmonaire |
| NZ517556A (en) | 1999-09-06 | 2003-08-29 | Ono Pharmaceutical Co | N-[o-(p-pivaloyloxybenzenesulphonyl-amino)benzoyl]glycine as preventive and therapeutic agents for eye diseases |
| US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
| US9205577B2 (en) * | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
| US11202853B2 (en) * | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH27266A (en) * | 1989-03-14 | 1993-05-04 | Fujisawa Pharmaceutical Co | WS7622, A,B,C and D substances and pharmaceutical composition containing same |
| GB9014546D0 (en) * | 1990-06-29 | 1990-08-22 | Fujisawa Pharmaceutical Co | Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof |
-
1992
- 1992-06-13 DK DK92109970.1T patent/DK0519354T3/da active
- 1992-06-13 ES ES92109970T patent/ES2111013T3/es not_active Expired - Lifetime
- 1992-06-13 AT AT92109970T patent/ATE161016T1/de not_active IP Right Cessation
- 1992-06-13 EP EP92109970A patent/EP0519354B1/fr not_active Expired - Lifetime
- 1992-06-13 DE DE69223455T patent/DE69223455T2/de not_active Expired - Fee Related
- 1992-06-17 US US07/899,915 patent/US5279826A/en not_active Expired - Fee Related
- 1992-06-17 CA CA002071425A patent/CA2071425C/fr not_active Expired - Fee Related
-
1997
- 1997-12-11 GR GR970403103T patent/GR3025656T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3025656T3 (en) | 1998-03-31 |
| CA2071425C (fr) | 1997-02-04 |
| ATE161016T1 (de) | 1997-12-15 |
| DE69223455D1 (de) | 1998-01-22 |
| DE69223455T2 (de) | 1998-04-02 |
| EP0519354B1 (fr) | 1997-12-10 |
| EP0519354A1 (fr) | 1992-12-23 |
| US5279826A (en) | 1994-01-18 |
| ES2111013T3 (es) | 1998-03-01 |
| DK0519354T3 (da) | 1998-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU645555B2 (en) | Improvements in or relating to the treatment of gastrointestinal disorders | |
| CA2230314A1 (fr) | Formulations pharmaceutiques contenant de la darifenacine | |
| EP1736147A3 (fr) | Formulations d'aérosols sans chlorofluorohydrocarbures | |
| CA2004239A1 (fr) | Utilisation de l'acetyl-d-carnitine dans le traitement therapeutique du glaucome et composes pharmaceutiques utiles dans un tel traitement | |
| CA2102630A1 (fr) | Compositions pharmaceutiques de medicaments compactes | |
| AU6060896A (en) | Oral 1alpha-hydroxyprevitamin D | |
| CA2258095A1 (fr) | Compositions contenant de la tetrahydrolipstatine | |
| WO1999059544A3 (fr) | Comprimes se desintegrant dans la bouche | |
| CA2024502A1 (fr) | Forme posologique pour l'administration orale de la glipizide hypoglycemique | |
| CA2179540A1 (fr) | Composition a liberation acceleree contenant de la bromocryptine | |
| CA2065652A1 (fr) | Formulations pharmaceutiques gastro-intestinales a liberation controlee pour administration orale contenant des acides biliaires et leurs sels | |
| PT85829A (en) | Therapeutic agents | |
| AU4297089A (en) | Dispersable formulation of diclofenac in free acid form | |
| CA2024872A1 (fr) | Medicaments | |
| ZA898667B (en) | Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment | |
| CA2071425A1 (fr) | Composition prophylactique/therapeutique pour la coagulation intravasculaire disseminee, ou les infections chroniques des voies respiratoires | |
| CA2038744A1 (fr) | Composition pharmaceutique contenant un medicament legerement hydrosoluble | |
| EP0425298A3 (en) | Sustained-release preparation of basic medical agent hydrochloride | |
| CA2069296A1 (fr) | Preparation combinee ayant une action antithrombotique | |
| CA2065889A1 (fr) | Augmentation du debit choroidien | |
| CA2167926A1 (fr) | Utilisation de benzydamine pour le traitement d'un etat pathologique cause par le tnf | |
| GB8820267D0 (en) | Pharmaceutical formulation | |
| AU4016189A (en) | Use of 2-azabicyclo(2.2.2) octane-3-carboxylic acid derivatives for the production of medicinal products intended for the treatment of diseases resulting from impairment of the vascular wall as well as for disorders of the microcirculation | |
| ZA968315B (en) | Administration by inhalation of 2-amino-6n-propyl-amino-4,5,,7-tetrahydrobenzothiazole particularly the (-)-enan-tiomer thereof and the pharmacologically acceptable acid addition salts thereof | |
| JPS57112328A (en) | Hypotensor comprising 2,3-dihydroxypropyl ester of n-(7- chloro-4-quinolyl)anthranillic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |